This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gardner, T. B.
Right arrow Articles by Hill, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gardner, T. B.
Right arrow Articles by Hill, D. R.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, January 2001, p. 114-128, Vol. 14, No. 1
0893-8512/01/$04.00+0   DOI: 10.1128/CMR.14.1.114-128.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Treatment of Giardiasis

Timothy B. Gardner and David R. Hill*

Division of Infectious Diseases, University of Connecticut Health Center, Farmington, Connecticut

Giardia lamblia is both the most common intestinal parasite in the United States and a frequent cause of diarrheal illness throughout the world. In spite of its recognition as an important human pathogen, there have been relatively few agents used in therapy. This paper discusses each class of drugs used in treatment, along with their mechanism of action, in vitro and clinical efficacy, and side effects and contraindications. Recommendations are made for the preferred treatment in different clinical situations. The greatest clinical experience is with the nitroimidazole drugs, i.e., metronidazole, tinidazole, and ornidazole, which are highly effective. A 5- to 7-day course of metronidazole can be expected to cure over 90% of individuals, and a single dose of tinidazole or ornidazole will cure a similar number. Quinacrine, which is no longer produced in the United States, has excellent efficacy but may be poorly tolerated, especially in children. Furazolidone is an effective alternative but must be administered four times a day for 7 to 10 days. Paromomycin may be used during early pregnancy, because it is not systematically absorbed, but it is not always effective. Patients who have resistant infection can usually be cured by a prolonged course of treatment with a combination of a nitroimidazole with quinacrine.

* Corresponding author. Mailing address: Division of Infectious Diseases, University of Connecticut Health Center, Farmington, CT 06030-3212. Phone: (860) 679-4700. Fax: (860) 679-4701. E-mail: dhill{at}exchange.uchc.edu.

Clinical Microbiology Reviews, January 2001, p. 114-128, Vol. 14, No. 1
0893-8512/01/$04.00+0   DOI: 10.1128/CMR.14.1.114-128.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Muller, J., Nillius, D., Hehl, A., Hemphill, A., Muller, N. (2009). Stable expression of Escherichia coli {beta}-glucuronidase A (GusA) in Giardia lamblia: application to high-throughput drug susceptibility testing. J Antimicrob Chemother 64: 1187-1191 [Abstract] [Full Text]  
  • de Saussure, P. P. H. (2009). Review: Management of the returning traveler with diarrhea. Therapeutic Advances in Gastroenterology 2: 367-375 [Abstract]  
  • Stark, D., Barratt, J. L. N., van Hal, S., Marriott, D., Harkness, J., Ellis, J. T. (2009). Clinical Significance of Enteric Protozoa in the Immunosuppressed Human Population. Clin. Microbiol. Rev. 22: 634-650 [Abstract] [Full Text]  
  • Escobedo, A A, Almirall, P, Alfonso, M, Cimerman, S, Rey, S, Terry, S L (2009). Treatment of intestinal protozoan infections in children. Arch. Dis. Child. 94: 478-482 [Abstract] [Full Text]  
  • Chandy, E., McCarthy, J. (2009). Evidence behind the WHO Guidelines: Hospital Care for Children: What is the most appropriate treatment for giardiasis?. J Trop Pediatr 55: 5-7 [Full Text]  
  • Muller, J., Ley, S., Felger, I., Hemphill, A., Muller, N. (2008). Identification of differentially expressed genes in a Giardia lamblia WB C6 clone resistant to nitazoxanide and metronidazole. J Antimicrob Chemother 62: 72-82 [Abstract] [Full Text]  
  • Sonda, S., Stefanic, S., Hehl, A. B. (2008). A Sphingolipid Inhibitor Induces a Cytokinesis Arrest and Blocks Stage Differentiation in Giardia lamblia. Antimicrob. Agents Chemother. 52: 563-569 [Abstract] [Full Text]  
  • Sterk, M., Muller, J., Hemphill, A., Muller, N. (2007). Characterization of a Giardia lamblia WB C6 clone resistant to the isoflavone formononetin. Microbiology 153: 4150-4158 [Abstract] [Full Text]  
  • Connelly, S. J., Wolyniak, E. A., Dieter, K. L., Williamson, C. E., Jellison, K. L. (2007). Impact of Zooplankton Grazing on the Excystation, Viability, and Infectivity of the Protozoan Pathogens Cryptosporidium parvum and Giardia lamblia. Appl. Environ. Microbiol. 73: 7277-7282 [Abstract] [Full Text]  
  • Muller, J., Sterk, M., Hemphill, A., Muller, N. (2007). Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole. J Antimicrob Chemother 60: 280-287 [Abstract] [Full Text]  
  • Muller, J., Wastling, J., Sanderson, S., Muller, N., Hemphill, A. (2007). A Novel Giardia lamblia Nitroreductase, GlNR1, Interacts with Nitazoxanide and Other Thiazolides. Antimicrob. Agents Chemother. 51: 1979-1986 [Abstract] [Full Text]  
  • Aijaz, B., Beckman, T. J. (2007). 25-Year-Old Man With Abdominal Pain, Nausea, and Fatigue. Mayo Clin Proc. 82: 359-362 [Full Text]  
  • Ali, V., Nozaki, T. (2007). Current Therapeutics, Their Problems, and Sulfur-Containing-Amino-Acid Metabolism as a Novel Target against Infections by "Amitochondriate" Protozoan Parasites. Clin. Microbiol. Rev. 20: 164-187 [Abstract] [Full Text]  
  • Shimizu, T., Tomioka, H. (2006). Activity of Picolinic Acid in Combination with the Antiprotozoal Drug Quinacrine against Mycobacterium avium Complex.. Antimicrob. Agents Chemother. 50: 3186-3188 [Abstract] [Full Text]  
  • Muller, J., Ruhle, G., Muller, N., Rossignol, J.-F., Hemphill, A. (2006). In Vitro Effects of Thiazolides on Giardia lamblia WB Clone C6 Cultured Axenically and in Coculture with Caco2 Cells. Antimicrob. Agents Chemother. 50: 162-170 [Abstract] [Full Text]  
  • Bertrand, I., Albertini, L., Schwartzbrod, J. (2005). Comparison of Two Target Genes for Detection and Genotyping of Giardia lamblia in Human Feces by PCR and PCR-Restriction Fragment Length Polymorphism. J. Clin. Microbiol. 43: 5940-5944 [Abstract] [Full Text]  
  • Benyacoub, J., Perez, P. F., Rochat, F., Saudan, K. Y., Reuteler, G., Antille, N., Humen, M., De Antoni, G. L., Cavadini, C., Blum, S., Schiffrin, E. J. (2005). Enterococcus faecium SF68 Enhances the Immune Response to Giardia intestinalis in Mice. J. Nutr. 135: 1171-1176 [Abstract] [Full Text]  
  • Humen, M. A., De Antoni, G. L., Benyacoub, J., Costas, M. E., Cardozo, M. I., Kozubsky, L., Saudan, K.-Y., Boenzli-Bruand, A., Blum, S., Schiffrin, E. J., Perez, P. F. (2005). Lactobacillus johnsonii La1 Antagonizes Giardia intestinalis In Vivo. Infect. Immun. 73: 1265-1269 [Abstract] [Full Text]  
  • Arguello-Garcia, R., Cruz-Soto, M., Romero-Montoya, L., Ortega-Pierres, G. (2004). Variability and variation in drug susceptibility among Giardia duodenalis isolates and clones exposed to 5-nitroimidazoles and benzimidazoles in vitro. J Antimicrob Chemother 54: 711-721 [Abstract] [Full Text]  
  • Bailey, J. M, Erramouspe, J. (2004). Nitazoxanide Treatment for Giardiasis and Cryptosporidiosis in Children. The Annals of Pharmacotherapy 38: 634-640 [Abstract] [Full Text]  
  • Nixon, J. E. J., Wang, A., Field, J., Morrison, H. G., McArthur, A. G., Sogin, M. L., Loftus, B. J., Samuelson, J. (2002). Evidence for Lateral Transfer of Genes Encoding Ferredoxins, Nitroreductases, NADH Oxidase, and Alcohol Dehydrogenase 3 from Anaerobic Prokaryotes to Giardialamblia and Entamoebahistolytica. Eukaryot Cell 1: 181-190 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»